Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Updates
Strategy Announces Establishment of $1.44 Billion USD Reserve and Updates FY 2025 Guidance
TYSONS CORNER, Va. – (BUSINESS WIRE) – December 1, 2025 – Strategy Inc (Nasdaq: STRF/STRC/STRK/STRD/MSTR; LuxSE: STRE) today announced the...
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal...
Financial and capital market updates
Market deals2025 outlookQ3 2025 was one of the strongest quarters in recent years, with global M&A deal value reaching USD...
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal...
Securities and Exchange Commission Updates Guidance for Public Co
Since the beginning of the year, the US Securities and Exchange Commission’s (SEC) Division of Corporation Finance staff (Corp Fin...
